[go: up one dir, main page]

CN201026212Y - Non-destructive detection device for blood glucose based on optical coherence tomography fundus imaging - Google Patents

Non-destructive detection device for blood glucose based on optical coherence tomography fundus imaging Download PDF

Info

Publication number
CN201026212Y
CN201026212Y CNU200620141296XU CN200620141296U CN201026212Y CN 201026212 Y CN201026212 Y CN 201026212Y CN U200620141296X U CNU200620141296X U CN U200620141296XU CN 200620141296 U CN200620141296 U CN 200620141296U CN 201026212 Y CN201026212 Y CN 201026212Y
Authority
CN
China
Prior art keywords
blood sugar
coherence tomography
optical coherence
broadband
tissue
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
CNU200620141296XU
Other languages
Chinese (zh)
Inventor
吴兰
尹伊
丁志华
徐向东
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Zhejiang University ZJU
Original Assignee
Zhejiang University ZJU
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Zhejiang University ZJU filed Critical Zhejiang University ZJU
Priority to CNU200620141296XU priority Critical patent/CN201026212Y/en
Application granted granted Critical
Publication of CN201026212Y publication Critical patent/CN201026212Y/en
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Images

Landscapes

  • Investigating Or Analysing Materials By Optical Means (AREA)

Abstract

本实用新型公开了一种光学相干层析技术眼底成像的血糖无损检测方法及装置。应用光学相干层析技术对人眼视网膜的毛细血管层进行层析成像,通过分析该层组织体的散射系数的变化来间接检测人体血糖含量,最终达到人体血糖的无损检测。该检测方法的装置采用光纤型光学相干层析技术系统,由宽带光源、2×2宽带光纤耦合器、位相调制器、快速扫描光学延迟线、偏振控制器、准直镜、物镜、探测器、XY方向扫描组件、前置放大器、数据采集卡、计算机等部分组成,利用上述方法可得到不同血糖浓度下人眼视网膜的毛细血管层的层析图像。本实用新型具有无损、层析以及高分辨率的特点,可以通过鉴别眼底视网膜毛细血管层的光强信息变化,反映出人体血糖的变化。

Figure 200620141296

The utility model discloses a method and a device for non-destructive detection of blood sugar by optical coherence tomography technology fundus imaging. Optical coherence tomography is applied to the tomographic imaging of the capillary layer of the human eye retina, and the blood sugar content of the human body is indirectly detected by analyzing the change of the scattering coefficient of the tissue in this layer, and finally the non-destructive detection of the human blood sugar is achieved. The device of the detection method adopts a fiber-optic optical coherence tomography system, which consists of a broadband light source, a 2×2 broadband fiber coupler, a phase modulator, a fast-scanning optical delay line, a polarization controller, a collimator, an objective lens, a detector, It is composed of an XY direction scanning component, a preamplifier, a data acquisition card, a computer, etc., and the tomographic image of the capillary layer of the human eye retina under different blood sugar concentrations can be obtained by using the above method. The utility model has the characteristics of non-destructive, tomographic and high-resolution, and can reflect the change of human blood sugar by identifying the change of light intensity information of the retinal capillary layer of the fundus.

Figure 200620141296

Description

光学相干层析技术眼底成像的血糖无损检测装置 Non-destructive detection device for blood glucose based on optical coherence tomography fundus imaging

技术领域technical field

本实用新型涉及基于光学相干层析技术眼底成像的血糖无损检测装置。The utility model relates to a blood sugar non-destructive detection device based on optical coherence tomography technology fundus imaging.

背景技术Background technique

随着人们生活水平的逐渐提高,人们的体力劳动量明显下降,同时伴随饮食结构的不合理,糖尿病越来越成为影响人们身体健康的一大疾病。糖尿病的危害在人体血糖含量的波动过大,从而引发各种并发疾病,如心血管、眼科等疾病,为使糖尿病人体内的血糖含量趋于合理,必须频繁检测病人的血糖含量,然后根据其含量的大小人工注射适量的药物来控制血糖含量。With the gradual improvement of people's living standards, people's physical labor has decreased significantly. At the same time, with the unreasonable diet structure, diabetes has become a major disease that affects people's health. The harm of diabetes is that the blood sugar content of the human body fluctuates too much, which leads to various concurrent diseases, such as cardiovascular and ophthalmological diseases. The size of the content is artificially injected with an appropriate amount of drugs to control the blood sugar content.

现有的通过美国FDA认证的血糖检测方法,都是有损或者微损检测方式,如美国强生公司的Onetouch血糖仪,这些仪器需要在人体采集一定量的血液样本,来测试人体的血糖含量。即使是微小的采血液量,对于每天要测试数次的病人来说也已经是非常痛苦了。相对于有损检测,无损检测方式有明显的优势:(1)减少患者每天采血测量的痛苦,提高病人的生活质量;(2)可方便地增加血糖测试次数,提高血糖控制精确度,降低糖尿病并发症发生的危险;(3)降低每次测量的成本。鉴于全世界庞大的糖尿病人数,无损血糖检测仪有着很大的市场空间,国外很多大公司和研究机构都投入了大量的精力来研究人体血糖的无损检测问题。国外研究比较多的方法有近红外光谱分析法、旋光偏振法、喇曼光谱分析法、光声法等,然而这些方法普遍存在信噪比低、精度和灵敏度不够高等缺点,到目前为止,都还无法得到临床应用。The existing blood glucose detection methods certified by the US FDA are all destructive or minimally destructive detection methods, such as the Onetouch blood glucose meter of Johnson & Johnson in the United States. These instruments need to collect a certain amount of blood samples from the human body to test the blood sugar content of the human body. Even a tiny amount of blood can be painful for a patient who needs to be tested several times a day. Compared with destructive testing, nondestructive testing methods have obvious advantages: (1) reduce the pain of daily blood sampling and measurement for patients, and improve the quality of life of patients; (2) can easily increase the number of blood sugar tests, improve the accuracy of blood sugar control, and reduce the risk of diabetes Risk of complications; (3) reduce the cost of each measurement. In view of the huge number of diabetics in the world, there is a large market space for non-destructive blood glucose detectors. Many large foreign companies and research institutions have devoted a lot of energy to research the non-destructive detection of human blood glucose. There are many methods studied abroad, such as near-infrared spectroscopy, optical rotation and polarization, Raman spectroscopy, photoacoustics, etc. Clinical application is not yet available.

光学相干层析技术(OCT)是新近发展的一种层析技术,但已在组织体的无损分析检测方面显示出了强大的实力,使其在检测生物组织体时能够达到很高的精度和分辨率。Optical coherence tomography (OCT) is a newly developed tomographic technology, but it has shown strong strength in the non-destructive analysis and detection of tissue, so that it can achieve high precision and accuracy in the detection of biological tissue. resolution.

人眼结构独特的光学特性,给眼底结构的光学成像带来了方便。光从眼瞳入射到处于视网膜最外层的色素层,再反射回来被光敏细胞探测。眼底视网膜结构层次分明,有着丰富的血管网络供应,为视神经以及视敏细胞提供养份。The unique optical properties of the human eye structure bring convenience to the optical imaging of the fundus structure. Light enters the pigmented layer, the outermost layer of the retina, from the pupil of the eye, and is reflected back to be detected by light-sensitive cells. The retinal structure of the fundus is well-structured and has a rich blood vessel network supply, which provides nutrients for the optic nerve and visual acuity cells.

眼底的视网膜层和脉络膜层的子层次结构都很清楚。供血层主要有两个:The sub-hierarchy of the retinal and choroidal layers of the fundus is clear. There are two main blood supply layers:

(a)紧邻视网膜的脉络层。脉络层有丰富的动、静脉血管和专门一层毛细血管层,提供养分给视网膜外层中光敏细胞(杆细胞和锥细胞)。(a) The choroid layer immediately adjacent to the retina. The choroid layer is rich in arterial and venous blood vessels and a specialized capillary layer that provides nutrients to the light-sensitive cells (rod cells and cone cells) in the outer layer of the retina.

(b)视网膜里层的供血层,动、静脉从视神经乳突处向外伸展,给整个视网膜内核层眼内的组织提供养分。(b) In the blood supply layer of the inner retina, the arteries and veins extend outward from the optic nerve mastoid, supplying nutrients to the tissues in the eye of the entire inner retinal layer.

根据Mie理论,散射体和散射体所在介质的折射率差会通过散射体系的散射系数反应出来。而血糖浓度的变化会改变组织体体液的折射率,进而影响组织体的整体散射系数。散射系数跟细胞内外的折射率差的关系,可以用公式表示如下:According to Mie theory, the refractive index difference between the scatterer and the medium in which the scatterer is located will be reflected by the scattering coefficient of the scattering system. The change of blood glucose concentration will change the refractive index of the tissue body fluid, and then affect the overall scattering coefficient of the tissue body. The relationship between the scattering coefficient and the difference in refractive index inside and outside the cell can be expressed as follows:

uu sthe s ′′ == 3.283.28 ππ rr 22 ρρ sthe s (( 22 πrπr λλ )) 0.370.37 (( nno sthe s nno mediummedium -- 11 )) 2.092.09 -- -- -- (( 11 ))

其中,r是散射球体的半径,ρs是单位体积里散射球体的个数,λ是入射光波长,ns为细胞内物质的折射率,nmedium为细胞外体液的折射率,且ns>nmedium。随着血糖浓度的增大,nmedium会变大,所以上式表示的散射系数会变小。反之,血糖浓度的变小,nmedium变小,散射系数变大。Among them, r is the radius of the scattering sphere, ρ s is the number of scattering spheres per unit volume, λ is the wavelength of the incident light, n s is the refractive index of the intracellular substance, n medium is the refractive index of the extracellular body fluid, and n s >n medium . As the blood sugar concentration increases, n medium will become larger, so the scattering coefficient represented by the above formula will become smaller. Conversely, the smaller the blood sugar concentration, the smaller the n medium , and the larger the scattering coefficient.

本实用新型探测的是组织体的后向散射信号,它的强度曲线斜率表征了组织体散射系数的大小。光在有散射和吸收的媒介中的衰减可近似表示为:The utility model detects the backscattering signal of the tissue, and the slope of its intensity curve characterizes the size of the scattering coefficient of the tissue. The attenuation of light in a medium with scattering and absorption can be approximated as:

II == II 00 ·· AeAe -- uu sthe s dd

随着组织体的血糖浓度变化,光在组织体中的强度信号指数衰减的斜率反应了us的大小,所以,通过OCT探测的组织体强度信号曲线,根据曲线斜率的数值,就能获得散射系数的大小,进而可间接获得组织体血糖浓度含量的大小。As the blood glucose concentration of the tissue changes, the slope of the exponential attenuation of the intensity signal in the tissue reflects the size of u s . Therefore, the intensity signal curve of the tissue detected by OCT can be obtained according to the value of the slope of the curve. The size of the coefficient can indirectly obtain the size of the blood glucose concentration in the tissue.

发明内容Contents of the invention

本实用新型的目的在于提供一种光学相干层析技术眼底成像的血糖无损检测装置。应用光学相干层析技术(OCT)对人眼视网膜的毛细血管层进行层析成像,通过分析该层组织体的散射系数的变化来间接检测人体血糖含量,最终达到人体血糖的无损检测。The purpose of the utility model is to provide a blood sugar non-destructive detection device for fundus imaging by optical coherence tomography. Optical coherence tomography (OCT) is used to perform tomographic imaging on the capillary layer of the human eye retina, and to indirectly detect the blood sugar content of the human body by analyzing the change in the scattering coefficient of the tissue in this layer, and finally achieve the non-destructive detection of human blood sugar.

为达到上述目的,本实用新型所采用的技术方案是:In order to achieve the above object, the technical solution adopted in the utility model is:

一、光学相干层析技术眼底成像的血糖无损检测方法1. Optical coherence tomography fundus imaging non-destructive detection method for blood sugar

应用光学相干层析技术对人眼视网膜的毛细血管层进行层析成像,通过分析该层组织体的散射系数的变化来间接检测人体血糖含量,最终达到人体血糖的无损检测;其方法的具体步骤如下:Using optical coherence tomography to perform tomographic imaging on the capillary layer of the human eye retina, and indirectly detect the blood sugar content of the human body by analyzing the change of the scattering coefficient of the tissue in this layer, and finally achieve the non-destructive detection of human blood sugar; the specific steps of the method as follows:

1)当一束光进入组织体后,光在组织体中的强度信号指数衰减的斜率反应了组织体的信息,通过OCT探测组织体强度信号曲线,根据曲线斜率的数值,就能获得散射系数的大小,由于血糖浓度的变化会改变组织体体液的折射率,进而影响组织体的整体散射系数,所以通过探测组织体的后向散射信号,它的强度曲线斜率就表征了组织体散射系数的大小;1) When a beam of light enters the tissue body, the slope of the exponential attenuation of the intensity signal of the light in the tissue body reflects the information of the tissue body. The intensity signal curve of the tissue body is detected by OCT, and the scattering coefficient can be obtained according to the value of the slope of the curve Since the change of blood glucose concentration will change the refractive index of the tissue body fluid, and then affect the overall scattering coefficient of the tissue body, so by detecting the backscattering signal of the tissue body, the slope of its intensity curve represents the scattering coefficient of the tissue body size;

2)人眼视网膜的毛细血管层的特定被测位置的后向散射光,进入OCT系统后,与样品光在光纤耦合器处汇合时发生干涉,通过XY方向扫描组件进行层面扫描,则得到该特定层的多点调制信号,然后由探测器和前置放大器转换为电信号,数据采集卡将该信号转换为数字信号,并由计算机进行图像重建工作,通过数据处理,可间接获得组织体血糖浓度含量的大小。2) After entering the OCT system, the backscattered light at a specific measured position of the capillary layer of the human eye interferes with the sample light when it merges at the fiber coupler, and scans the slice through the XY direction scanning component to obtain the The multi-point modulation signal of a specific layer is then converted into an electrical signal by the detector and the preamplifier. The data acquisition card converts the signal into a digital signal, and the image is reconstructed by the computer. Through data processing, the tissue blood sugar can be obtained indirectly. The size of the concentration content.

二、光学相干层析技术眼底成像的血糖无损检测装置2. Optical coherence tomography fundus imaging non-destructive detection device for blood sugar

宽带光源低相干光经光纤入射到2×2宽带光纤耦合器,经分光后分别进入参考臂和样品臂,进入参考臂的一路通过位相调制器后,然后进入依次由准直镜、衍射光栅、傅里叶变换透镜和振镜组成的快速扫描系统;进入样品臂的一路依次经偏振控制器、准直镜、XY方向扫描组件和准直镜和物镜投射于样品池;两路反射光经2×2宽带光纤耦合器汇合时发生干涉后,接入探测器和前置放大器,依次与数据采集卡、计算机电气连接。The low-coherent light of the broadband light source enters the 2×2 broadband fiber coupler through the optical fiber, and enters the reference arm and the sample arm respectively after being split. Fast scanning system composed of Fourier transform lens and vibrating mirror; one path entering the sample arm is projected onto the sample cell through polarization controller, collimating mirror, XY direction scanning component, collimating mirror and objective lens in turn; two paths of reflected light pass through 2 After the interference occurs when the ×2 broadband fiber couplers converge, they are connected to the detector and the preamplifier, and are electrically connected to the data acquisition card and the computer in turn.

本实用新型与背景技术相比具有的有益效果是:The beneficial effect that the utility model has compared with background technology is:

(一)用光学相干层析技术(OCT)方法对眼底成像无损检测人体血糖含量,相对于对皮肤的OCT检测,它有如下优势:(1) Optical coherence tomography (OCT) is used to non-destructively detect human blood sugar levels on fundus imaging. Compared with OCT detection on skin, it has the following advantages:

a.皮肤对探测光波长(1310nm)虽然有比较大的探测深度(1~2mm),但是其表面的角质层对光信号的衰减较大,而眼睛却对该探测光几乎是透明的,探测深度可达2~3cm。a. Although the skin has a relatively large detection depth (1-2mm) for the detection light wavelength (1310nm), the cuticle on the surface of the skin has a relatively large attenuation of the light signal, but the eyes are almost transparent to the detection light. The depth can reach 2-3cm.

b.真皮组织中有大量的毛囊、脂肪团等大组织体干扰OCT探测信号,而视网膜结构相对均匀,而且其分层结构非常明显,对于OCT层析成像的特点来说,能更加有效检测。b. There are a large number of large tissues such as hair follicles and fat in the dermis that interfere with OCT detection signals, while the retinal structure is relatively uniform, and its layered structure is very obvious, which can be more effectively detected for the characteristics of OCT tomography.

c.人眼的供血系统比皮肤的供血系统丰富,血糖含量的变化对组织散射系数变化影响大,对检测有利。c. The blood supply system of the human eye is richer than the blood supply system of the skin, and the change of blood sugar content has a great influence on the change of tissue scattering coefficient, which is beneficial to the detection.

(二)通过用OCT检测散射系数的变化来间接检测人体血糖含量,相对于其他无损检测方法,该方法有高精度、高灵敏度以及层析带来的高抗干扰性等特点。(2) By using OCT to detect changes in the scattering coefficient to indirectly detect the blood sugar content of the human body. Compared with other non-destructive detection methods, this method has the characteristics of high precision, high sensitivity, and high anti-interference brought by chromatography.

(三)通过建立眼底毛细血管层散射模型,进而可以通过检测模型中糖浓度的变化进行仿组织体散射系数变化的微球模拟体系。(3) By establishing the scattering model of the capillary layer of the fundus, the microsphere simulation system that can simulate the change of the tissue scattering coefficient can be carried out by detecting the change of the sugar concentration in the model.

(四)由于本装置的结构为非接触测量,类似于眼科检查,因此容易被接受,使用操作亦比较方便。(4) Since the structure of the device is non-contact measurement, which is similar to eye examination, it is easy to be accepted and convenient to use and operate.

附图说明Description of drawings

图1是本实用新型基于光学相干层析技术对眼底成像的血糖无损检测装置的结构图;Fig. 1 is the structural diagram of the nondestructive detection device for blood sugar based on optical coherence tomography technology of the present invention for fundus imaging;

图2是OCT信号及拟合强度曲线图;Fig. 2 is a curve diagram of OCT signal and fitting intensity;

图3是不同折射率溶液的OCT信号强度曲线比较图。Fig. 3 is a comparison diagram of OCT signal intensity curves of solutions with different refractive indices.

图中:1、宽带光源,2、光纤,3、2×2宽带光纤耦合器,4、位相调制器,5、快速扫描系统,5-1、准直镜,5-2、衍射光栅,5-3、傅里叶变换透镜,5-4、振镜,6、偏振控制器,7、准直镜和物镜,8、探测器和前置放大器,9、数据采集卡,10、XY方向扫描组件,11、计算机,12、样品池。In the figure: 1. Broadband light source, 2. Optical fiber, 3. 2×2 broadband fiber coupler, 4. Phase modulator, 5. Fast scanning system, 5-1. Collimating mirror, 5-2. Diffraction grating, 5 -3. Fourier transform lens, 5-4. Galvanometer, 6. Polarization controller, 7. Collimator and objective lens, 8. Detector and preamplifier, 9. Data acquisition card, 10. Scanning in XY direction Components, 11, computer, 12, sample cell.

具体实施方式Detailed ways

根据Mie理论,散射体和散射体所在介质的折射率差会通过散射体系的散射系数反应出来。而血糖浓度的变化会改变组织体体液的折射率,进而影响组织体的整体散射系数。散射系数跟细胞内外的折射率差的关系,可以用公式表示如下:According to Mie theory, the refractive index difference between the scatterer and the medium in which the scatterer is located will be reflected by the scattering coefficient of the scattering system. The change of blood glucose concentration will change the refractive index of the tissue body fluid, and then affect the overall scattering coefficient of the tissue body. The relationship between the scattering coefficient and the difference in refractive index inside and outside the cell can be expressed as follows:

uu sthe s ′′ == 3.283.28 ππ rr 22 ρρ sthe s (( 22 πrπr λλ )) 0.370.37 (( nno sthe s nno mediummedium -- 11 )) 2.092.09 -- -- -- (( 11 ))

其中,r是散射球体的半径,ρs是单位体积里散射球体的个数,λ是入射光波长,ns为细胞内物质的折射率,nmedium为细胞外体液的折射率,且ns>nmedium。随着血糖浓度的增大,nmedium会变大,所以上式表示的散射系数会变小。反之,血糖浓度的变小,nmedium变小,散射系数变大。Among them, r is the radius of the scattering sphere, ρ s is the number of scattering spheres per unit volume, λ is the wavelength of the incident light, n s is the refractive index of the intracellular substance, n medium is the refractive index of the extracellular body fluid, and n s >n medium . As the blood sugar concentration increases, n medium will become larger, so the scattering coefficient represented by the above formula will become smaller. Conversely, the smaller the blood sugar concentration, the smaller the n medium , and the larger the scattering coefficient.

本实用新型探测的是组织体的后向散射信号,它的强度曲线斜率表征了组织体散射系数的大小。光在有散射和吸收的媒介中的衰减可近似表示为:The utility model detects the backscattering signal of the tissue, and the slope of its intensity curve characterizes the size of the scattering coefficient of the tissue. The attenuation of light in a medium with scattering and absorption can be approximated as:

II == II 00 ·&Center Dot; AeAe -- uu sthe s dd

随着组织体的血糖浓度变化,光在组织体中的强度信号指数衰减的斜率反应了us的大小,所以,通过OCT探测的组织体强度信号曲线,根据曲线斜率的数值,就能获得散射系数的大小,进而可间接获得组织体血糖浓度含量的大小。As the blood glucose concentration of the tissue changes, the slope of the exponential attenuation of the intensity signal in the tissue reflects the size of u s . Therefore, the intensity signal curve of the tissue detected by OCT can be obtained according to the value of the slope of the curve. The size of the coefficient can indirectly obtain the size of the blood glucose concentration in the tissue.

本实用新型的装置如图1所示,它由宽带光源1、光纤、2×2宽带光纤耦合器3、位相调制器4、快速扫描系统5、偏振控制器6、准直镜和物镜7、探测器和前置放大器8、数据采集卡9、XY方向扫描组件10、计算机11组成。宽带光源1低相干光经光纤2入射到2×2宽带光纤耦合器3,经分光后分别进入参考臂和样品臂,进入参考臂的一路通过位相调制器4后,然后进入依次由准直镜5-1、衍射光栅5-2、傅里叶变换透镜5-3和振镜5-4组成的快速扫描系统5;进入样品臂的一路依次经偏振控制器6、准直镜、XY方向扫描组件10和物镜7投射于样品池12;两路反射光经2×2宽带光纤耦合器3汇合时发生干涉后,接入探测器和前置放大器8,依次与数据采集卡9、计算机11电气连接。The device of the present utility model is shown in Figure 1, and it is by broadband light source 1, optical fiber, 2 * 2 broadband optical fiber couplers 3, phase modulator 4, fast scanning system 5, polarization controller 6, collimating mirror and objective lens 7, Detector and preamplifier 8, data acquisition card 9, XY direction scanning component 10, computer 11. The low-coherent light of broadband light source 1 enters the 2×2 broadband fiber coupler 3 through the optical fiber 2, and enters the reference arm and the sample arm respectively after being split. 5-1, fast scanning system 5 composed of diffraction grating 5-2, Fourier transform lens 5-3 and vibrating mirror 5-4; the way into the sample arm is scanned in turn by polarization controller 6, collimating mirror, XY direction The component 10 and the objective lens 7 are projected on the sample cell 12; after the two reflected lights are combined by the 2×2 broadband fiber coupler 3 and interfere with each other, they are connected to the detector and the preamplifier 8, and are connected to the data acquisition card 9 and the computer 11 in turn. connect.

人眼视网膜的毛细血管层的特定被测位置的后向散射光,进入OCT系统后,与样品光在光纤耦合器处汇合时发生干涉,通过XY方向扫描组件进行层面扫描,则得到该特定层的多点调制信号,然后由探测器和前置放大器转换为电信号;数据采集卡将该信号转换为数字信号,并由计算机进行图像重建工作。The backscattered light at a specific measured position of the capillary layer of the human retina, after entering the OCT system, interferes with the sample light when it merges at the fiber coupler, and scans the layer through the XY direction scanning component to obtain the specific layer The multi-point modulation signal is then converted into an electrical signal by the detector and the preamplifier; the data acquisition card converts the signal into a digital signal, and the image reconstruction is performed by the computer.

图2是模型的OCT图像及其经过横向平均处理的深度信号强度曲线,其曲线的指数斜率反应了散射系数的大小。根据OCT信号的指数斜率以及系统分辨率,可以算得具体的散射系数。Figure 2 is the OCT image of the model and its depth signal intensity curve after horizontal average processing. The exponential slope of the curve reflects the size of the scattering coefficient. According to the exponential slope of the OCT signal and the system resolution, the specific scattering coefficient can be calculated.

图3显示了不同掺糖浓度的聚苯乙烯微球悬浊液的OCT深度信号曲线,图中的曲线表明6个样品的散射系数的关系为3-1>3-2>3-3>3-4>3-5>3-6,与理论计算结果一致。图中实验数据证明,OCT能够检测到5%糖浓度变化引起的模型散射系数的变化,从而验证了用OCT方法的检测人体血糖含量的可行性。Figure 3 shows the OCT depth signal curves of polystyrene microsphere suspensions with different sugar concentrations. The curves in the figure show that the relationship of the scattering coefficients of the six samples is 3-1>3-2>3-3>3 -4>3-5>3-6, consistent with the theoretical calculation results. The experimental data in the figure proves that OCT can detect the change of model scattering coefficient caused by the change of 5% sugar concentration, thus verifying the feasibility of using OCT method to detect human blood sugar content.

(1)对眼底毛细血管层的OCT散射检测(1) OCT scattering detection of fundus capillary layer

散射方法比较适合于毛细血管比较丰富而且散射比较明显的组织体部位,眼底有两个供血层,分别位于光敏细胞层之前和之后,血糖浓度的改变在该处对组织体液的折射率的影响较大。因此,准确快速地寻找到两个供血层,并获得重复性好的后向散射信号是本实用新型的主要内容。The scattering method is more suitable for tissue body parts with rich capillaries and obvious scattering. There are two blood supply layers in the fundus, which are respectively located in front of and behind the photosensitive cell layer. big. Therefore, it is the main content of the utility model to find the two blood supply layers accurately and quickly, and obtain the backscattering signal with good repeatability.

考虑到OCT信号中,多次散射光的相互干扰,实际要建立的关系要复杂的多。OCT信号曲线的获得需要通过对原始OCT信号数据进行处理得到,由于OCT检测的是后向散射相干光信号,通过扫描臂的轴向扫描,可以获得不同深度层的散射光强度信息。经过横向多次平均,可以得到均匀稳定的以深度为自变量的OCT散射强度曲线。由于眼底视网膜的子层有随着位置的不同在厚度上有比较大的变化,所以横向平均需要考虑目标层的在不同位置处的深度差异问题。Considering the mutual interference of multiple scattered lights in the OCT signal, the actual relationship to be established is much more complicated. The acquisition of the OCT signal curve needs to be obtained by processing the original OCT signal data. Since OCT detects backscattered coherent light signals, the scattered light intensity information of different depth layers can be obtained through the axial scanning of the scanning arm. After multiple horizontal averages, a uniform and stable OCT scattering intensity curve with depth as an independent variable can be obtained. Since the sublayers of the fundus retina have relatively large changes in thickness with different positions, the horizontal averaging needs to consider the depth difference of the target layer at different positions.

(2)对视网膜中央静脉血管内血液的OCT散射检测(2) OCT scattering detection of blood in the central retinal vein

鉴于视网膜的血管比较粗大(一般最大直径可达150um),在视神经乳头处有比较粗的静脉血管,相对于OCT的um级的分辨率,已经足够检测,加上血液的散射系数比较大,由血糖浓度变化引起的散射会更加明显。所以,寻找理想被测血管,在获取信号的前提下,寻找血管内的合理检测点,获取最佳的相关性。In view of the relatively thick retinal blood vessels (generally the largest diameter can reach 150um), there are relatively thick veins and blood vessels at the optic nerve head. Compared with the um-level resolution of OCT, it is enough for detection, and the scattering coefficient of blood is relatively large. Scattering due to changes in blood glucose concentration will be more pronounced. Therefore, to find the ideal blood vessel to be measured, on the premise of obtaining the signal, find a reasonable detection point in the blood vessel to obtain the best correlation.

本实用新型基于光学相干层析技术对眼底成像的血糖无损检测方法包括如下步骤:The utility model is based on the optical coherence tomography technology, and the blood sugar non-destructive detection method of fundus imaging comprises the following steps:

(一)从宽带光源出来的低相干光入射到2×2宽带光纤耦合器,经分光后分别进入参考臂和样品臂。(1) The low-coherent light from the broadband light source is incident on the 2×2 broadband fiber coupler, and enters the reference arm and the sample arm respectively after being split.

(二)进入参考臂的光先通过位相调制器(Phase modulator),然后进入由准直镜、衍射光栅、傅里叶变换透镜和振镜组成的快速扫描光学延迟线(RapidScanning Optical Delay Line,RSOD)。(2) The light entering the reference arm first passes through the phase modulator (Phase modulator), and then enters the rapid scanning optical delay line (Rapid Scanning Optical Delay Line, RSOD) composed of collimating mirror, diffraction grating, Fourier transform lens and galvanometer ).

(三)入射到样品臂上的光经偏振控制器后,通过准直镜和物镜投射于眼底视网膜的毛细血管层。(3) The light incident on the sample arm is projected on the capillary layer of the fundus retina through the collimating lens and the objective lens after passing through the polarization controller.

(四)从参考臂和样品臂返回的光,如果所经历的光程差在光源的相干长度以内,则在光纤耦合器处汇合时发生干涉,如果进行层面扫描,则得到任意一个断层的多点调制信号。(4) The light returned from the reference arm and the sample arm, if the experienced optical path difference is within the coherence length of the light source, interference will occur when they meet at the fiber coupler. Click to modulate the signal.

(五)将产生的干涉信号经过探测器和前置放大器后输到数据采集卡,并由计算机进行后续处理和图像重建,从而获得眼底视网膜的毛细血管层的层析图像。(5) The generated interference signal is transmitted to the data acquisition card after passing through the detector and the preamplifier, and the subsequent processing and image reconstruction are carried out by the computer, so as to obtain the tomographic image of the capillary layer of the fundus retina.

本实用新型所用的宽带光源发出的光是低相干光,其中心波长λ=1310nm,带宽Δλ=65nm。The light emitted by the broadband light source used in the utility model is low coherence light, its central wavelength λ=1310nm, and the bandwidth Δλ=65nm.

该装置对样品在Z方向的扫描通过RSOD实现,XY方向扫描选择样品扫描方式,利用二维电动微位移平台实现。The device scans the sample in the Z direction through RSOD, and selects the sample scanning mode for XY direction scanning, which is realized by using a two-dimensional electric micro-displacement platform.

本实用新型采用了干涉信号的载频技术,将参考臂中的PM的位相调制频率设在500KHz,使信号与低频噪音在频域上能有效分离。The utility model adopts the carrier frequency technology of the interference signal, and sets the phase modulation frequency of the PM in the reference arm at 500KHz, so that the signal and the low-frequency noise can be effectively separated in the frequency domain.

本实用新型采用低噪音前置放大器实施电路滤波和后续软件的数字滤波。The utility model adopts a low-noise preamplifier to implement circuit filtering and subsequent software digital filtering.

选用各构件连接组成本装置,其中:宽带光源1选用B & W Tek.公司生产的中心波长λ=1310nm,带宽Δλ=65nm的光源;光纤2,可选南京玻璃纤维研究院生产的配有收集透镜的石英光纤(芯径0.1mm,数值孔径0.37);2×2宽带光纤耦合器3选用杭州富通公司生产的分光度50/50,带宽80nm的宽带光纤耦合器;位相调制器4选用JDS Uniphase公司生产的产品;快速扫描系统5由准直镜5-1、衍射光栅5-2、傅里叶变换透镜5-3、振镜5-4依次连接构成,其中准直镜5-1与与位相调制器4通过光耦合连接;偏振控制器6其一端与2×2宽带光纤耦合器3通过光纤连接,一端和准直镜7通过光耦合连接;准直镜和物镜7可选用浙江舜宇集团的常规产品;探测器和前置放大器8选用日本滨松公司的产品;数据采集卡9选用Gage Applied公司的Compuscopel2100型高速采集卡(采集速率为10MHz);XY方向扫描组件10是一个二维电动微位移平台,可使样品池12在二维平面上做微小位移;计算机11可选用奔腾586以上微机,并配有GPIB卡;样品池12用有机玻璃材料制成,并在两侧开有一对窗口,镶有石英窗片,其厚度为1mm,样品池中的模拟介质是聚苯乙烯微球悬浊液,模拟的目标组织是一个胶质立方体(5mm×5mm×5mm),用来代替人眼底视网膜毛细血管层。The device is composed of various components connected, among which: the broadband light source 1 is a light source with a central wavelength λ=1310nm and a bandwidth Δλ=65nm produced by B & W Tek.; The quartz optical fiber of the lens (core diameter 0.1mm, numerical aperture 0.37); 2×2 broadband fiber coupler 3 chooses a broadband fiber coupler with a spectral ratio of 50/50 and a bandwidth of 80nm produced by Hangzhou Futong Company; the phase modulator 4 chooses JDS The product that Uniphase Company produces; Fast scanning system 5 is connected successively by collimating mirror 5-1, diffraction grating 5-2, Fourier transform lens 5-3, vibrating mirror 5-4 and constitutes, and wherein collimating mirror 5-1 and It is connected to the phase modulator 4 through optical coupling; one end of the polarization controller 6 is connected to the 2×2 broadband fiber coupler 3 through optical fiber, and the other end is connected to the collimator 7 through optical coupling; the collimator and objective lens 7 can be selected from Zhejiang Shun Conventional product of Yu Group; Detector and preamplifier 8 select the product of Hamamatsu Company of Japan for use; Data acquisition card 9 selects the Compusscopepel2100 type high-speed acquisition card (acquisition rate is 10MHz) of Gage Applied Company for use; XY direction scanning assembly 10 is a two-dimensional The three-dimensional electric micro-displacement platform can make the sample pool 12 do a small displacement on the two-dimensional plane; the computer 11 can be a Pentium 586 or above microcomputer, and is equipped with a GPIB card; the sample pool 12 is made of plexiglass material, and opened on both sides There are a pair of windows, inlaid with quartz windows, the thickness of which is 1mm, the simulated medium in the sample cell is polystyrene microsphere suspension, and the simulated target tissue is a colloidal cube (5mm×5mm×5mm), used to Replacing the retinal capillary layer of the human fundus.

Claims (1)

1. The blood sugar nondestructive testing device of the optical coherence tomography eyeground imaging is characterized in that: the method comprises the following steps that low-coherence light of a broadband light source (1) enters a 2 x 2 broadband optical fiber coupler (3) through an optical fiber (2), is split and then respectively enters a reference arm and a sample arm, enters one path of the reference arm, passes through a phase modulator (4), and then enters a fast scanning system (5) which sequentially consists of a collimating lens (5-1), a diffraction grating (5-2), a Fourier transform lens (5-3) and a vibrating lens (5-4); one path entering the sample arm is projected to a sample cell (12) through a polarization controller (6), a collimating mirror, an XY direction scanning component (10), the collimating mirror and an objective lens (7) in sequence; after two paths of reflected light generate interference when being converged by the 2 multiplied by 2 broadband optical fiber coupler (3), the two paths of reflected light are connected into a detector and a preamplifier (8) and are electrically connected with a data acquisition card (9) and a computer (11) in sequence.
CNU200620141296XU 2006-12-21 2006-12-21 Non-destructive detection device for blood glucose based on optical coherence tomography fundus imaging Expired - Lifetime CN201026212Y (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CNU200620141296XU CN201026212Y (en) 2006-12-21 2006-12-21 Non-destructive detection device for blood glucose based on optical coherence tomography fundus imaging

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CNU200620141296XU CN201026212Y (en) 2006-12-21 2006-12-21 Non-destructive detection device for blood glucose based on optical coherence tomography fundus imaging

Publications (1)

Publication Number Publication Date
CN201026212Y true CN201026212Y (en) 2008-02-27

Family

ID=39130412

Family Applications (1)

Application Number Title Priority Date Filing Date
CNU200620141296XU Expired - Lifetime CN201026212Y (en) 2006-12-21 2006-12-21 Non-destructive detection device for blood glucose based on optical coherence tomography fundus imaging

Country Status (1)

Country Link
CN (1) CN201026212Y (en)

Cited By (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN100438829C (en) * 2006-12-21 2008-12-03 浙江大学 Non-destructive detection device for blood glucose based on optical coherence tomography fundus imaging
CN102349834A (en) * 2011-06-20 2012-02-15 深圳职业技术学院 Human body blood sugar concentration noninvasive detection method and system thereof
CN103315749A (en) * 2013-05-30 2013-09-25 苏州光环科技有限公司 Skin area positioning device, method and system applicable to blood glucose detection
WO2013159280A1 (en) * 2012-04-24 2013-10-31 深圳市斯尔顿科技有限公司 Ophthalmic optical coherence tomography system and protomerite/deutomerite imaging method by quick switching
JP2017099748A (en) * 2015-12-03 2017-06-08 株式会社吉田製作所 Optical coherence tomographic image display control device and program thereof
CN114376528A (en) * 2022-01-14 2022-04-22 湖南大学 Abnormal cell non-stop flow imaging screening system in blood vessel based on correlation imaging
CN116807396A (en) * 2023-03-06 2023-09-29 南昌大学第一附属医院 Optical coherence tomography system for hair follicle detection

Cited By (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN100438829C (en) * 2006-12-21 2008-12-03 浙江大学 Non-destructive detection device for blood glucose based on optical coherence tomography fundus imaging
CN102349834A (en) * 2011-06-20 2012-02-15 深圳职业技术学院 Human body blood sugar concentration noninvasive detection method and system thereof
WO2013159280A1 (en) * 2012-04-24 2013-10-31 深圳市斯尔顿科技有限公司 Ophthalmic optical coherence tomography system and protomerite/deutomerite imaging method by quick switching
CN103315749A (en) * 2013-05-30 2013-09-25 苏州光环科技有限公司 Skin area positioning device, method and system applicable to blood glucose detection
CN103315749B (en) * 2013-05-30 2015-01-14 苏州光环科技有限公司 Skin area positioning device, method and system applicable to blood glucose detection
JP2017099748A (en) * 2015-12-03 2017-06-08 株式会社吉田製作所 Optical coherence tomographic image display control device and program thereof
CN114376528A (en) * 2022-01-14 2022-04-22 湖南大学 Abnormal cell non-stop flow imaging screening system in blood vessel based on correlation imaging
CN114376528B (en) * 2022-01-14 2024-08-09 湖南大学 A non-stop imaging screening system for abnormal cells in blood vessels based on correlation imaging
CN116807396A (en) * 2023-03-06 2023-09-29 南昌大学第一附属医院 Optical coherence tomography system for hair follicle detection

Similar Documents

Publication Publication Date Title
Berardesca et al. Bioengineering of the skin: Methods and instrumentation, Volume III
Hosseinaee et al. Functional and structural ophthalmic imaging using noncontact multimodal photoacoustic remote sensing microscopy and optical coherence tomography
Izatt et al. Optical coherence tomography for biodiagnostics
US20050190372A1 (en) Interferometric sensor for characterizing materials
US20050151976A1 (en) Method for monitoring of analytes in biological samples using low coherence interferometry
JP2003531357A (en) Optical sensor with selectable sampling distance for analyte determination
Chen et al. Monte Carlo investigation of optical coherence tomography retinal oximetry
Iftimia et al. Toward noninvasive measurement of blood hematocrit using spectral domain low coherence interferometry and retinal tracking
CN100438829C (en) Non-destructive detection device for blood glucose based on optical coherence tomography fundus imaging
Wang et al. Optical coherence elastography and its applications for the biomechanical characterization of tissues
CN201026212Y (en) Non-destructive detection device for blood glucose based on optical coherence tomography fundus imaging
John et al. Glucose sensing in the anterior chamber of the human eye model using supercontinuum source based dual wavelength low coherence interferometry
CN109691978A (en) Relevant optical scanning ophthalmoscope towards ocular blood flow fast imaging
CN209301156U (en) A kind of system based on OCT technology measurement blood oxygen saturation
Cheing et al. The potential influence of diabetic history on peripheral blood flow in superficial skin
RU2438130C2 (en) Method for blood cell analysis for glucose content
John et al. Glucose sensing in ex-vivo human gingival tissue with enhanced sensitivity in combination band
Talukdar Non-Invasive Measurement of Glucose Content in Human Body: A Comparative Study
Koul et al. Non-invasive Sub-Terahertz Blood Glucose Measurement
McAuley Probing sub-resolution tissue structural and mechanical properties with optical coherence tomography
Hosseinaee et al. Non-contact, in-vivo, functional, and structural ophthalmic imaging using multimodal photoacoustic remote sensing (PARS) microscopy and optical coherence tomography (OCT)
Beard et al. 3D photoacoustic scanner based on an optical ultrasound-mapping system for imaging superficial vascular anatomy in vivo
Fikadu et al. Research Article Investigation of Light Parameters on Image Quality and Optical Coherence Tomography
Untracht Strategies towards in situ high resolution optical coherence tomography in cardiovascular science and physiology
Yu et al. High‐Resolution Optical Coherence Tomography (OCT) for Skin Imaging

Legal Events

Date Code Title Description
C14 Grant of patent or utility model
GR01 Patent grant
AV01 Patent right actively abandoned

Effective date of abandoning: 20081203

C25 Abandonment of patent right or utility model to avoid double patenting